{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T19:30:44Z","timestamp":1780342244872,"version":"3.54.1"},"reference-count":97,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroent\u00e9rologie Clinique et Biologique"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.gcb.2009.02.037","type":"journal-article","created":{"date-parts":[[2009,4,25]],"date-time":"2009-04-25T05:41:08Z","timestamp":1240638068000},"page":"370-381","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Liver and inflammatory bowel disease"],"prefix":"10.1016","volume":"33","author":[{"given":"S.","family":"Nahon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-F.","family":"Cadranel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Chazouilleres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Biour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Jouannaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Marteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gcb.2009.02.037_bib1","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0889-8553(01)00020-6","article-title":"Hepatobiliary disease in inflammatory bowel disease","volume":"31","author":"Ahmad","year":"2002","journal-title":"Gastroenterol Clin N Am"},{"key":"10.1016\/j.gcb.2009.02.037_bib2","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0889-8553(05)70067-4","article-title":"Hepatobiliary manifestations of inflammatory bowel disease","volume":"28","author":"Raj","year":"1999","journal-title":"Gastroenterol Clin N Am"},{"key":"10.1016\/j.gcb.2009.02.037_bib3","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1080\/00365520410005162","article-title":"Subnormal alanine aminotransferase values in blood of patients with Crohn disease","volume":"39","author":"Vadstrup","year":"2004","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.gcb.2009.02.037_bib4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/00365529850166275","article-title":"Hepatobiliary alterations in patients with inflammatory bowel disease: a multicenter study. Caprilli & Gruppo Italiano Studio Colon-Retto","volume":"33","author":"Riegler","year":"1998","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.gcb.2009.02.037_bib5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/00365529108996489","article-title":"Prevalence of hepatobiliary dysfunction in a regional group of patients with chronic inflammatory bowel disease","volume":"26","author":"Wewer","year":"1991","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.gcb.2009.02.037_bib6","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/00004836-200305000-00012","article-title":"Sonographic prevalence of liver steatosis and biliary tract stones in patients with inflammatory bowel disease: study of 511 subjects at a single center","volume":"36","author":"Bargiggia","year":"2003","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.gcb.2009.02.037_bib7","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0140-6736(02)07374-9","article-title":"Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease","volume":"359","author":"Grant","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.gcb.2009.02.037_bib8","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/00365520600787994","article-title":"Changes over a 20-year period in the clinical presentation of primary sclerosing cholangitis in Sweden","volume":"42","author":"Bergquist","year":"2007","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.gcb.2009.02.037_bib9","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/0016-5085(88)90378-2","article-title":"Primary sclerosing cholangitis with normal serum alkaline phosphatase activity","volume":"95","author":"Balasubramaniam","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gcb.2009.02.037_bib10","first-page":"307","article-title":"Maladies des voies biliaires intrah\u00e9patiques\u00a0: diagnostic et principes du traitement","volume":"27","author":"Chazouill\u00e8res","year":"2003","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.gcb.2009.02.037_bib11","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1136\/jcp.48.10.933","article-title":"Sampling variability of percutaneous liver biopsy in primary sclerosing cholangitis","volume":"48","author":"Olsson","year":"1995","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.gcb.2009.02.037_bib12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF01887799","article-title":"Sclerosing cholangitis: broad spectrum of radiographic features","volume":"9","author":"Chen","year":"1984","journal-title":"Gastrointest Radiol"},{"key":"10.1016\/j.gcb.2009.02.037_bib13","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0168-8278(00)80002-1","article-title":"Magnetic resonance cholangiography in patients with biliary disease: its role in primary sclerosing cholangitis","volume":"33","author":"Angulo","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.gcb.2009.02.037_bib14","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.gie.2005.12.034","article-title":"Diagnosis of primary sclerosing cholangitis: a blinded comparative study using magnetic resonance cholangiography and endoscopic retrograde cholangiography","volume":"64","author":"Moff","year":"2006","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.gcb.2009.02.037_bib15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/s-2006-933561","article-title":"Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer","volume":"26","author":"Broome","year":"2006","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.gcb.2009.02.037_bib16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/gut.2004.046615","article-title":"PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis","volume":"54","author":"Loftus","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.gcb.2009.02.037_bib17","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/gut.35.1.84","article-title":"Liver disease in ulcerative colitis: an epidemiological and follow up study in the county of Stockholm","volume":"35","author":"Broome","year":"1994","journal-title":"Gut"},{"key":"10.1016\/j.gcb.2009.02.037_bib18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1055\/s-2008-1040417","article-title":"Small-duct primary sclerosing cholangitis","volume":"11","author":"Ludwig","year":"1991","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.gcb.2009.02.037_bib19","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1053\/j.gastro.2008.01.042","article-title":"The natural history of small-duct primary sclerosing cholangitis","volume":"134","author":"Bjornsson","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gcb.2009.02.037_bib20","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.21685","article-title":"Immunoglobulin G4 associated cholangitis: description of an emerging clinical entity based on review of the literature","volume":"45","author":"Bjornsson","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.gcb.2009.02.037_bib21","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/j.gastro.2007.12.009","article-title":"Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy","volume":"134","author":"Ghazale","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gcb.2009.02.037_bib22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1750-1172-2-29","article-title":"Low phospholipid associated cholelithiasis: association with mutation in the MDR3\/ABCB4 gene","volume":"2","author":"Rosmorduc","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.gcb.2009.02.037_bib23","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/hep.21405","article-title":"Sclerosing cholangitis: a focus on secondary causes","volume":"44","author":"Abdalian","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.gcb.2009.02.037_bib24","first-page":"72","article-title":"Biliary tract calculi in primary sclerosing cholangitis","volume":"90","author":"Kaw","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gcb.2009.02.037_bib25","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/j.1572-0241.1999.01076.x","article-title":"The prevalence of gallstone disease in a defined cohort of patients with Crohn's disease","volume":"94","author":"Lapidus","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gcb.2009.02.037_bib26","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/hep.21537","article-title":"Incidence and risk factors for gallstones in patients with inflammatory bowel disease: a large case-control study","volume":"45","author":"Parente","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.gcb.2009.02.037_bib27","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1007\/s10350-004-6798-4","article-title":"Cholecystectomy in patients with Crohn's ileitis","volume":"46","author":"Chew","year":"2003","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.gcb.2009.02.037_bib28","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1007\/s10620-005-3057-z","article-title":"Development of primary biliary cirrhosis in a patient with Crohn's disease: a case report and review of the literature","volume":"50","author":"Jang","year":"2005","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gcb.2009.02.037_bib29","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3748\/wjg.v9.i4.878","article-title":"Primary biliary cirrhosis and ulcerative colitis: a case report and review of literature","volume":"9","author":"Xiao","year":"2003","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gcb.2009.02.037_bib30","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-2559.1994.tb01321.x","article-title":"Hepatic granulomas in Northern Ireland: a thirteen-year review","volume":"25","author":"McCluggage","year":"1994","journal-title":"Histopathology"},{"key":"10.1016\/j.gcb.2009.02.037_bib31","first-page":"A102","article-title":"Influence of infliximab on abdominal fat tissue and metabolic syndrome in Crohn's disease (abstract)","volume":"132","author":"Parmentier-Decrucq","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gcb.2009.02.037_bib32","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s10067-007-0539-8","article-title":"Impact of TNF inhibition on insulin resistance and lipids levels in patients with rheumatoid arthritis","volume":"26","author":"Tam","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.gcb.2009.02.037_bib33","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1111\/j.1440-1746.2004.03368.x","article-title":"Liver abscess in inflammatory bowel disease: report of two cases and review of the literature","volume":"19","author":"Margalit","year":"2004","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.gcb.2009.02.037_bib34","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/01.MIB.0000225336.06732.90","article-title":"Liver abscesses as the presenting manifestation of Crohn's disease in an adolescent","volume":"12","author":"Navot-Mintzer","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gcb.2009.02.037_bib35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.gassur.2005.04.006","article-title":"Staphylococcal liver abscess and acute cholecystitis in a patient with Crohn's disease receiving infliximab","volume":"10","author":"Patel","year":"2006","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.gcb.2009.02.037_bib36","first-page":"175","article-title":"Maladie de Crohn et vaisseaux","volume":"22","author":"Nahon","year":"1998","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.gcb.2009.02.037_bib37","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S1542-3565(05)00154-0","article-title":"Thrombosis in inflammatory bowel disease","volume":"3","author":"Irving","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gcb.2009.02.037_bib38","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1572-0241.2007.01646_18.x","article-title":"Portal vein thrombosis in a patient with quiescent Crohn's disease associated with hyperhomocysteinemia and antiphospholipid antibody syndrome one year after an ileocaecal resection","volume":"103","author":"Racine","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gcb.2009.02.037_bib39","doi-asserted-by":"crossref","first-page":"5582","DOI":"10.3748\/wjg.v12.i34.5582","article-title":"Portal venous gas and thrombosis in a Chinese patient with fulminant Crohn's colitis: a case report with literature review","volume":"12","author":"Ng","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gcb.2009.02.037_bib40","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/j.1572-0241.1999.00959.x","article-title":"Crohn's disease presenting as septic thrombophlebitis of the portal vein (pylephlebitis): case report and review of the literature","volume":"94","author":"Baddley","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gcb.2009.02.037_bib41","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0248-8663(01)00537-9","article-title":"Unusual association: hepatic peliosis and Crohn's disease","volume":"23","author":"Launay","year":"2002","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.gcb.2009.02.037_bib42","first-page":"611","article-title":"Aspects IRM des anomalies sinuso\u00efdales et p\u00e9ri-sinuso\u00efdales du parenchyme h\u00e9patique","volume":"83","author":"Cognet","year":"2002","journal-title":"J Radiol"},{"key":"10.1016\/j.gcb.2009.02.037_bib43","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00004836-200003000-00016","article-title":"Budd-Chiari syndrome in a patient with ulcerative colitis: association with anticardiolipin antibodies","volume":"30","author":"Praderio","year":"2000","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.gcb.2009.02.037_bib44","first-page":"417","article-title":"Hepatic vein thrombosis (Budd-Chiari syndrome) in an adolescent with ulcerative colitis","volume":"25","author":"Kraut","year":"1997","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.gcb.2009.02.037_bib45","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1136\/gut.27.9.1096","article-title":"Ulcerative colitis complicated by Budd-Chiari syndrome","volume":"27","author":"Chesner","year":"1986","journal-title":"Gut"},{"key":"10.1016\/j.gcb.2009.02.037_bib46","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/gut.51.4.536","article-title":"Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines","volume":"51","author":"Ransford","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.gcb.2009.02.037_bib47","first-page":"119","article-title":"Sulfasalazine-induced fulminant hepatitis in pediatric Crohn's disease: report of two cases","volume":"26","author":"Besnard","year":"1998","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.gcb.2009.02.037_bib48","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2036.1992.tb00544.x","article-title":"Clinical tolerance to three 5-aminosalicylic acid releasing preparations in patients with inflammatory bowel disease intolerant or allergic to sulphasalazine","volume":"6","author":"Giaffer","year":"1992","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gcb.2009.02.037_bib49","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S0399-8320(04)95062-2","article-title":"Drug-induced liver injury; fourteenth updated edition of the bibliographic database of liver injuries and related drugs","volume":"28","author":"Biour","year":"2004","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.gcb.2009.02.037_bib50","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0168-8278(97)80061-X","article-title":"Cholestasis associated with mesalazine therapy in a patient with Crohn's disease","volume":"26","author":"Stoschus","year":"1997","journal-title":"J Hepatol"},{"key":"10.1016\/j.gcb.2009.02.037_bib51","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1136\/gut.44.6.886","article-title":"Mesalazine (5-aminosalicylic acid) induced chronic hepatitis","volume":"44","author":"Deltenre","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.gcb.2009.02.037_bib52","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1111\/j.1572-0241.1999.01245.x","article-title":"Mesalamine-induced granulomatous hepatitis","volume":"94","author":"Braun","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gcb.2009.02.037_bib53","first-page":"708","article-title":"Azodisalicylate (Dipentum) \u2013 induced hepatitis","volume":"11","author":"Mulder","year":"1989","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.gcb.2009.02.037_bib54","first-page":"A154","article-title":"Cohorte nationale CESAME (Cancers et sur-risque associ\u00e9 aux maladies inflammatoires chroniques intestinales en France)\u00a0: donn\u00e9es d\u00e9mographiques et m\u00e9dicales 2004\u20132005 pour 20\u00a0919 patients (r\u00e9sum\u00e9)","volume":"29","author":"Beaugerie","year":"2006","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.gcb.2009.02.037_bib55","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1111\/j.1572-0241.2007.01187.x","article-title":"Thiopurine-induced liver injury in patients with inflammatory bowel disease: a systematic review","volume":"102","author":"Gisbert","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gcb.2009.02.037_bib56","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1365-2036.2005.02636.x","article-title":"Incidence, risk factors and clinical course of thiopurine-induced liver injury in patients with inflammatory bowel disease","volume":"22","author":"Bastida","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gcb.2009.02.037_bib57","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0016-5085(00)70140-5","article-title":"Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease","volume":"118","author":"Dubinsky","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gcb.2009.02.037_bib58","first-page":"444","article-title":"Myelotoxicity and hepatotoxicity during azathioprine therapy","volume":"63","author":"De Boer","year":"2005","journal-title":"Neth J Med"},{"key":"10.1016\/j.gcb.2009.02.037_bib59","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/j.1572-0241.2003.07413.x","article-title":"Thioguanine: a potential alternate thiopurine for IBD patients allergic to 6-mercaptopurine or azathioprine","volume":"98","author":"Dubinsky","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gcb.2009.02.037_bib60","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0016-5085(03)00938-7","article-title":"6-thioguanine can cause serious liver injury in inflammatory bowel disease patients","volume":"125","author":"Dubinsky","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gcb.2009.02.037_bib61","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1136\/gut.2006.114363","article-title":"Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine","volume":"56","author":"Vernier-Massouille","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.gcb.2009.02.037_bib62","first-page":"A7","article-title":"Hyperplasie nodulaire r\u00e9g\u00e9n\u00e9rative sous azathioprine au cours des MICI (r\u00e9sum\u00e9)","volume":"31","author":"Cosnes","year":"2007","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.gcb.2009.02.037_bib63","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0399-8320(05)82136-0","article-title":"Azathioprine induced nodular regenerative hyperplasia in IBD patients","volume":"29","author":"Daniel","year":"2005","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.gcb.2009.02.037_bib64","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-2002-23204","article-title":"Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease)","volume":"22","author":"DeLeve","year":"2002","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.gcb.2009.02.037_bib65","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jhep.2005.02.051","article-title":"A multicenter assessment of liver toxicity by MRI and biopsy in IBD patients on 6-thioguanine","volume":"43","author":"Seiderer","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.gcb.2009.02.037_bib66","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2036.2006.02742.x","article-title":"Review article: updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome","volume":"23","author":"Helmy","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gcb.2009.02.037_bib67","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00042737-200103000-00013","article-title":"Veno-occlusive disease, nodular regenerative hyperplasia and hepatocellular carcinoma after azathioprine treatment in a patient with ulcerative colitis","volume":"13","author":"Russmann","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.gcb.2009.02.037_bib68","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/00054725-200409000-00023","article-title":"Acute sinusoidal obstruction syndrome after 6-thioguanine therapy for Crohn's disease","volume":"10","author":"Kane","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gcb.2009.02.037_bib69","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/hep.510230326","article-title":"Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: the role of glutathione and relevance to hepatic venoocclusive disease","volume":"23","author":"DeLeve","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.gcb.2009.02.037_bib70","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/gut.51.2.275","article-title":"Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients","volume":"51","author":"Hillaire","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.gcb.2009.02.037_bib71","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1053\/hupa.2000.7629","article-title":"Hepatocellular carcinoma and focal hepatic glycogenosis after prolonged azathioprine therapy","volume":"31","author":"Cattan","year":"2000","journal-title":"Hum Pathol"},{"key":"10.1016\/j.gcb.2009.02.037_bib72","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1007\/s10620-005-9009-9","article-title":"Hepatocellular carcinoma occurring in a patient with Crohn's disease treated with both azathioprine and infliximab","volume":"51","author":"Chen","year":"2006","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gcb.2009.02.037_bib73","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.gcb.2007.11.002","article-title":"Foie et m\u00e9thotrexate","volume":"32","author":"Laharie","year":"2008","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.gcb.2009.02.037_bib74","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0190-9622(98)70508-0","article-title":"Methotrexate in psoriasis: consensus conference","volume":"38","author":"Roenigk","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.gcb.2009.02.037_bib75","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1046\/j.1365-2036.2004.01819.x","article-title":"Monitoring methotrexate-induced hepatic fibrosis in patients with psoriasis: are serial liver biopsies justified?","volume":"19","author":"Aithal","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gcb.2009.02.037_bib76","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJM200006013422202","article-title":"A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators","volume":"342","author":"Feagan","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gcb.2009.02.037_bib77","first-page":"1730","article-title":"Methotrexate in Crohn's disease: long-term efficacy and toxicity","volume":"95","author":"Lemann","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gcb.2009.02.037_bib78","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1365-2036.2005.02343.x","article-title":"Review article: monitoring of immunomodulators in inflammatory bowel disease","volume":"21","author":"Aberra","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gcb.2009.02.037_bib79","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1111\/j.1365-2036.2006.02929.x","article-title":"Diagnosis of liver fibrosis by transient elastography (FibroScan) and non-invasive methods in Crohn's disease patients treated with methotrexate","volume":"23","author":"Laharie","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gcb.2009.02.037_bib80","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(02)08512-4","article-title":"Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial","volume":"359","author":"Hanauer","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.gcb.2009.02.037_bib81","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/S0140-6736(99)05246-0","article-title":"Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group","volume":"354","author":"Maini","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.gcb.2009.02.037_bib82","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4065\/76.1.84","article-title":"Infliximab-associated reversible cholestatic liver disease","volume":"76","author":"Menghini","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.gcb.2009.02.037_bib83","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s10067-005-0169-y","article-title":"Serious liver disease induced by infliximab","volume":"26","author":"Tobon","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.gcb.2009.02.037_bib84","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1136\/ard.2004.032821","article-title":"Autoimmune hepatitis associated with infliximab in a patient with psoriatic arthritis","volume":"64","author":"Germano","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.gcb.2009.02.037_bib85","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2165\/00063030-200721020-00007","article-title":"Adalimumab: in Crohn's disease","volume":"21","author":"Plosker","year":"2007","journal-title":"BioDrugs"},{"key":"10.1016\/j.gcb.2009.02.037_bib86","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1136\/ard.2003.009563","article-title":"Efficay and safety of the fully human anti-tumor necrosis factor alpha monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study","volume":"62","author":"van de Putte","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.gcb.2009.02.037_bib87","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1056\/NEJMoa067594","article-title":"Certolizumab pegol for the treatment of Crohn's disease","volume":"357","author":"Sandborn","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gcb.2009.02.037_bib88","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1056\/NEJMoa062897","article-title":"Maintenance therapy with certolizumab pegol for Crohn's disease","volume":"357","author":"Schreiber","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gcb.2009.02.037_bib89","first-page":"671","article-title":"Efficacit\u00e9 du traitement par la lamivudine au cours de deux cas de r\u00e9activations s\u00e9v\u00e8res d\u2019une h\u00e9patite B, induite par l\u2019arr\u00eat d\u2019un traitement chimioth\u00e9rapique","volume":"24","author":"Seksik","year":"2000","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.gcb.2009.02.037_bib90","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/gut.2004.040675","article-title":"Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis","volume":"53","author":"Esteve","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.gcb.2009.02.037_bib91","first-page":"1624","article-title":"Fulminant hepatitis after infliximab in a patient with hepatitis B virus treated for an adult onset still's disease","volume":"30","author":"Michel","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.gcb.2009.02.037_bib92","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1136\/ard.62.7.686","article-title":"Hepatitis B reactivation in a chronic hepatitis B surface antigen carrier with rheumatoid arthritis treated with infliximab and low dose methotrexate","volume":"62","author":"Ostuni","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.gcb.2009.02.037_bib93","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jhep.2008.10.001","article-title":"EASL clinical practice guidelines: management of chronic hepatitis B","volume":"50","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.gcb.2009.02.037_bib94","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2036.2005.02556.x","article-title":"Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case-control study","volume":"22","author":"Bargiggia","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gcb.2009.02.037_bib95","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/j.1365-2036.2008.03812.x","article-title":"Interaction of ribavirin with azathioprine metabolism potentially induces myelosuppression","volume":"28","author":"Peyrin-Biroulet","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gcb.2009.02.037_bib96","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/MPG.0b013e31802f6424","article-title":"Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease","volume":"44","author":"Mackey","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.gcb.2009.02.037_bib97","series-title":"World Health Organization Classification of tumors \/pathology and genetics of tumors of haematopoietic and lymphoid tissues","author":"Jaffe","year":"2001"}],"container-title":["Gastroent\u00e9rologie Clinique et Biologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399832009001328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399832009001328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:48:27Z","timestamp":1759974507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399832009001328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":97,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0399832009001328"],"URL":"https:\/\/doi.org\/10.1016\/j.gcb.2009.02.037","relation":{},"ISSN":["0399-8320"],"issn-type":[{"value":"0399-8320","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver and inflammatory bowel disease","name":"articletitle","label":"Article Title"},{"value":"Gastroent\u00e9rologie Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gcb.2009.02.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}